23-May-2007 - Albany Molecular Research, Inc. (AMRI)

AMRI Acquires Manufacturing Facilities in India

Albany Molecular Research, Inc. has signed a definitive agreement to acquire two pharmaceutical manufacturing sites, along with additional land for future expansion, in Aurangabad and Navi Mumbai, India. Under the terms of the agreement, AMRI will acquire the assets - including facilities, employees, products and equipment - of Ariane Orgachem Pvt. Ltd. in Aurangabad and Ferico Laboratories Ltd. in Navi Mumbai for approximately $11 million in cash. All of the facilities are currently owned by the Runwal Group and manufacture a range of pharmaceutical intermediates and bulk active ingredients, including treatments for diabetes, heart disease and asthma. As part of the purchase, AMRI will obtain additional land in Aurangabad and plans to invest approximately U.S. $15 million to expand capabilities there over the next three years. The proposed expansion includes increasing capacity, as well as bringing these facilities into compliance with U.S. Food and Drug Administration regulations for manufacturing clinical trial materials and commercial drug substances. Subject to customary closing conditions, the transaction is expected to close during the second or third quarter of 2007. The purchase is projected to be neutral to slightly dilutive to AMRI's earnings by approximately ($0.01) to ($0.02) this year, and accretive by the end of 2008. In fiscal year 2006, these assets collectively generated approximately U.S. $5 million in revenue.

Facts, background information, dossiers
  • food
  • diabetes
  • clinical trials
  • asthma
  • Albany Molecular Research
More about Albany Molecular Research
  • News

    AMRI to Close Holywell, U.K. API Manufacturing Facility

    AMRI announced that it has decided to close its Holywell, U.K. facility following a consultation process with employee representatives. The Holywell site provides chemical development services and small- and large scale-manufacturing services of active pharmaceutical ingredients (API) and i ... more

    AMRI Opens New Research Facility in Budapest, Hungary

    AMRI announced that it has finished the construction of a new state-of-the-art chemistry R&D facility in Budapest, Hungary. The successful completion and move into 32,300 square feet (3,000 square meters) of laboratory and administrative space marks a significant milestone in the company’s ... more

    AMRI Names Senior Director, Analytical and Quality Services

    AMRI announced that Junan Guo, Ph.D. has joined the company as senior director, analytical and quality services. Dr. Guo fills the role vacated by Dr. Steven Hagen, who was promoted to vice president of pharmaceutical development and manufacturing in September 2008. Dr. Guo will oversee a ... more

  • Companies

    Albany Molecular Research, Inc. (AMRI)

    Founded in 1991 as Albany Molecular Research, Inc., AMRI provides scientific services, products and technologies focused on improving the quality of life. The company has steadily evolved, with global facilities now in the United States, Europe and Asia. Its 1,200+ employees have the expe ... more